NCT01082172已完成不适用
A Pilot Trial to Evaluate the Performance of the TriVascular Thoracic Stent Graft System
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2
- 试验地点
- 1
- 主要终点
- Absence of device-related serious adverse events within 30-days of endovascular procedure
研究概览
简要总结
A prospective, non-randomized multi-center clinical evaluation of the performance of the TriVascular Thoracic Stent Graft System when used in the treatment of subjects with thoracic aortic aneurysms (TAA).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The TriVascular Thoracic Stent Graft System is indicated in subjects diagnosed with an aneurysm in the descending thoracic aorta having vascular morphology suitable for endovascular repair, including:
- •Adequate iliac/femoral access compatible with the required delivery systems,
- •Non-aneurysmal aortic segments proximal and distal to the aneurysm.
排除标准
- 未提供
研究组 & 干预措施
Thoracic Stent Graft
Experimental
Thoracic Stent Graft implanted device
干预措施: Implant Thoracic Stent Graft (Device)
结局指标
主要结局
Absence of device-related serious adverse events within 30-days of endovascular procedure
时间窗: 30-Days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A prospective multi-center randomized clinical trial to compare survival rates and to observe quality of life and nutritional status according to follow-up period in patients who underwent radical gastrectomy for advanced gastric cancerNeoplasmsKCT0006547ational Cancer Center886
已完成
不适用
An Observational, Prospective Evaluation of the Trifecta™ ValveRegurgitation, Aortic ValveAortic Valve IncompetenceAortic Valve InsufficiencyAortic Valve StenosisNCT00727181Abbott Medical Devices120
已完成
4 期
A prospective, multicentre study to see the safety of Osimertinib in Indian adult patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive nonsmall cell lung cancer.CTRI/2018/10/015941AstraZeneca Pharma India Limited60
进行中（未招募）
4 期
Study to check safety of Durvalumab in Indian patients with non-small cell lung cancerCTRI/2020/08/027287AstraZeneca Pharma India Ltd
进行中（未招募）
不适用
REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /Uncontrolled Stage 2 HypertensionNCT05372679SoniVie Inc.25